|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| C07D 487/04 | (2013.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3728261 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18829264.3 |
| Date of filing the European patent application | 2018-12-13 | |
| (97) | Date of publication of the European application | 2020-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/084691 |
| Date | 2018-12-13 |
| (87) | Number | WO 2019/121290 |
| Date | 2019-06-27 |
| (30) | Number | Date | Country code |
| 17208942 | 2017-12-20 | EP | |
| 18172429 | 2018-05-15 | EP | |
| 18199511 | 2018-10-10 | EP |
| (72) |
ENKELMANN, Dennis, Dimo , AT
|
| (73) |
Sandoz AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | CO-CRYSTAL OF AN ORALLY AVAILABLE JANUS KINASE INHIBITOR |
| CO-CRYSTAL OF AN ORALLY AVAILABLE JANUS KINASE INHIBITOR |